March 2024 Stock Gainers on News, Micro Caps Included
Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.
Data as of the trading session of , 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
Whole board, unfiltered
100
Ranked gains
+568.69%
Largest, GCTS
92.8%
Above baseline, day +5
6.1%
Median give-back, day +5
Filter and sort
100 ranked gains in March 2024
Skip the ranked rows and go to the month summaryEvery percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.
| Rank | Symbol | close to close | Session | Catalyst | Announcement | from the pre-news close |
|---|---|---|---|---|---|---|
| 1 | GCTS | +568.69% |
against the close of 2024-03-26
session reconstructed
Session detail |
Reverse Merger / Shell |
GCT Semiconductor Becomes a Publicly Traded Company After Completing Business Combination with Concord Acquisition Corp III, Will Commence Trading on NYSE Under Ticker Symbol "GCTS"
18:30 ET after hours |
It gave back the whole move and closed 12.92% below the pre-news price. Month end +402.43% on 2024-03-28 This month ended before the fifth session after the move. |
| 2 | AVTX | +357.89% |
against the close of 2024-03-27
session reconstructed
Session detail |
M&A / Acquisition |
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
16:01 ET after hours |
31.5% of the move was gone five sessions later. Month end +357.89% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 3 | NEPT Also on the opposite board this month on both boards | +269.00% |
against the close of 2024-03-07
session reconstructed
Session detail |
Leadership Change |
Neptune Appoints Interim President and CEO and Interim COO
08:30 ET premarket |
40.2% of the move was gone five sessions later. Month end +100.00% on 2024-03-28 |
| 4 | VERB | +211.41% |
against the close of 2024-03-14
session reconstructed
Session detail |
Other Announcement |
VERB's MARKET.live Launches Facebook and Instagram Social Shopping Technology Integration
08:30 ET premarket |
33.8% of the move was gone five sessions later. Month end +86.62% on 2024-03-28 |
| 5 | AISP | +200.00% |
against the close of 2024-03-04
session reconstructed
Session detail |
Contract / Partnership |
Airship AI Announces Significant Sole-Source Contract Award within the Department of Justice for Acropolis Enterprise Video and Data Management Platform
08:31 ET premarket |
Five sessions later the move was 81.8% bigger, at +363.64%. Month end +299.39% on 2024-03-28 |
| 6 | IBIO | +192.17% |
against the close of 2024-03-26
session reconstructed
Session detail |
Contract / Partnership |
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
07:00 ET premarket |
39.4% of the move was gone five sessions later. Month end +253.04% on 2024-03-28 This month ended before the fifth session after the move. |
| 7 | XPDB | +181.44% |
against the close of 2024-03-08
session reconstructed
Session detail |
Contract / Partnership |
GE Vernova and Montana Technologies Close Joint Venture to Manufacture Transformational Air Conditioning and Atmospheric Water Harvesting Products
08:30 ET premarket |
Month-end is not shown: no closing price is available for 2024-03-28. |
| 8 | IMRN under $25M today release reads negative | +175.76% |
against the close of 2024-03-06
session reconstructed
Session detail |
Clinical Trial Results Release reads negative, stock rose 175.76% |
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
06:00 ET premarket |
59.7% of the move was gone five sessions later. Month end +59.39% on 2024-03-28 |
| 9 | LABP | +173.31% |
against the close of 2024-03-22
session reconstructed
Session detail |
M&A / Acquisition |
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
08:30 ET premarket |
Five sessions later the move was 0.9% bigger, at +174.84%. Month end +174.33% on 2024-03-28 This month ended before the fifth session after the move. |
| 10 | XTLB under $25M today | +128.85% |
against the close of 2024-03-19
session reconstructed
Session detail |
Other Announcement |
XTL To Aquire The Social Proxy
10:15 ET intraday |
Five sessions later the move was 23.9% bigger, at +159.62%. Month end +170.19% on 2024-03-28 |
| 11 | CLRO under $25M today | +127.55% |
against the close of 2024-03-11
session reconstructed
Session detail |
Buyback / Dividend |
ClearOne Announces a Special One-time Cash Dividend
16:45 ET after hours |
28.6% of the move was gone five sessions later. Month end +102.14% on 2024-03-28 |
| 12 | HNRA under $25M today | +121.21% |
against the close of 2024-03-11
session reconstructed
Session detail |
Reverse Merger / Shell |
HNR Acquisition Corp Announces a Significant Increase in Potential Oil Recovery from the Grayburg-Jackson Field
13:45 ET intraday |
55.9% of the move was gone five sessions later. Month end +32.19% on 2024-03-28 |
| 13 | LSF | +104.30% |
against the close of 2024-03-12
session reconstructed
Session detail |
Earnings |
Laird Superfood Reports Fourth Quarter and Fiscal Year 2023 Financial Results
17:47 ET after hours |
Five sessions later the move was 90.7% bigger, at +198.92%. Month end +158.06% on 2024-03-28 |
| 14 | FUSN | +99.06% |
against the close of 2024-03-18
session reconstructed
Session detail |
M&A / Acquisition |
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
03:00 ET premarket |
Five sessions later the move was 1.1% bigger, at +100.19%. Month end +100.38% on 2024-03-28 |
| 15 | BREA | +91.18% |
against the close of 2024-03-06
session reconstructed
Session detail |
M&A / Acquisition |
Seasoned Investment Banker Dan McClory Acquires Majority Stake in Brera Holdings
17:49 ET after hours |
53.8% of the move was gone five sessions later. Month end +26.47% on 2024-03-28 |
| 16 | NXL under $25M today More than one ranked move this month 2+ ranked moves | +79.49% |
against the close of 2024-03-27
session reconstructed
Session detail |
Clinical Trial Results |
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
08:30 ET premarket |
Five sessions later the move was 175.8% bigger, at +219.23%. Month end +79.49% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 17 | MESO | +78.64% |
against the close of 2024-03-25
session reconstructed
Session detail |
FDA & Regulatory |
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
22:34 ET after hours |
Five sessions later the move was 138.1% bigger, at +187.27%. Month end +127.73% on 2024-03-28 This month ended before the fifth session after the move. |
| 18 | CDLX release reads negative | +77.15% |
against the close of 2024-03-14
session reconstructed
Session detail |
Earnings Release reads negative, stock rose 77.15% |
Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
16:03 ET after hours |
Five sessions later the move was 22.2% bigger, at +94.26%. Month end +77.03% on 2024-03-28 |
| 19 | PHUN | +75.28% |
against the close of 2024-03-01
session reconstructed
Session detail |
Earnings |
Phunware Sets Fourth Quarter and Full Year 2023 Earnings Call for Tuesday, March 12, 2024 at 4:30 PM ET
08:30 ET premarket |
37.3% of the move was gone five sessions later. Month end +26.55% on 2024-03-28 |
| 20 | IDN | +74.86% |
against the close of 2024-03-21
session reconstructed
Session detail |
Earnings |
Intellicheck Announces Fourth Quarter and Full-Year 2023 Financial Results
16:05 ET after hours |
Five sessions later the move was 16.8% bigger, at +87.43%. Month end +98.86% on 2024-03-28 This month ended before the fifth session after the move. |
| 21 | RGLS | +71.01% |
against the close of 2024-03-11
session reconstructed
Session detail |
Clinical Trial Results |
Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
06:30 ET premarket |
Five sessions later the move was 2.6% bigger, at +72.83%. Month end +108.70% on 2024-03-28 |
| 22 | XLO | +69.01% |
against the close of 2024-03-27
session reconstructed
Session detail |
Contract / Partnership |
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
07:00 ET premarket |
Five sessions later the move was 27.2% bigger, at +87.79%. Month end +69.01% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 23 | CURI release reads negative | +65.09% |
against the close of 2024-03-20
session reconstructed
Session detail |
Buyback / Dividend Release reads negative, stock rose 65.09% |
CuriosityStream Announces Fourth Quarter and Full Year 2023 Financial Results and Initiation of Dividend Program
16:15 ET after hours |
Five sessions later the move was 29.1% bigger, at +84.01%. Month end +84.01% on 2024-03-28 |
| 24 | CRDF | +64.87% |
against the close of 2024-02-29
session reconstructed
Session detail |
Clinical Trial Results |
Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)
16:05 ET after hours |
Five sessions later the move was 107.4% bigger, at +134.56%. Month end +202.55% on 2024-03-28 |
| 25 | DAVE | +64.38% |
against the close of 2024-03-04
session reconstructed
Session detail |
Earnings |
Dave Reports Record Fourth Quarter and Full Year 2023 Results; Reaches Significant Quarterly Profitability Milestone
07:30 ET premarket |
6.1% of the move was gone five sessions later. Month end +69.59% on 2024-03-28 |
| 26 | DTSS under $25M today | +63.77% |
against the close of 2024-03-04
session reconstructed
Session detail |
Other Announcement |
Datasea Expects Approximately 1,128% Revenue Growth in 2024
10:45 ET intraday |
13.7% of the move was gone five sessions later. Month end +36.77% on 2024-03-28 |
| 27 | RVSN under $25M today | +59.90% |
against the close of 2024-03-05
session reconstructed
Session detail |
Other Announcement |
Rail Vision Deploys its Groundbreaking AI Safety System in a National Railways Line
09:07 ET premarket |
13.6% of the move was gone five sessions later. Month end +8.63% on 2024-03-28 |
| 28 | SCX | +58.87% |
against the close of 2024-03-08
session reconstructed
Session detail |
M&A / Acquisition |
The L.S. Starrett Company Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company
07:00 ET premarket |
Five sessions later the move was 0.7% bigger, at +59.27%. Month end +60.18% on 2024-03-28 |
| 29 | STOK More than one ranked move this month 2+ ranked moves | +58.31% |
against the close of 2024-03-25
session reconstructed
Session detail |
Earnings catalyst from a later release the same session |
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
16:01 ET after hours |
Five sessions later the move was 66.6% bigger, at +97.15%. Month end +107.69% on 2024-03-28 This month ended before the fifth session after the move. |
| 30 | LIXT | +59.96% Recomputed from this session's own closing prices: the stored figure of +56.10% disagrees with them by 3.86 points. The rank is the one the stored figure gave this row. |
against the close of 2024-03-22
session reconstructed
Session detail |
Other Announcement |
NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES
08:30 ET premarket |
7.6% of the move was gone five sessions later. Month end +53.60% on 2024-03-28 This month ended before the fifth session after the move. |
| 31 | REAL | +55.93% |
against the close of 2024-02-29
session reconstructed
Session detail |
Earnings |
The RealReal Announces Fourth Quarter and Full Year 2023 Results
16:15 ET after hours |
Five sessions later the move was 90.9% bigger, at +106.78%. Month end +120.90% on 2024-03-28 |
| 32 | ALLG release reads negative | +53.86% |
against the close of 2024-03-26
session reconstructed
Session detail |
Other Announcement Release reads negative, stock rose 53.86% |
Allego Schedules Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
16:05 ET after hours |
15.0% of the move was gone five sessions later. Month end +67.75% on 2024-03-28 This month ended before the fifth session after the move. |
| 33 | BIVI under $25M today Also on the opposite board this month on both boards | +52.42% |
against the close of 2024-02-29
session reconstructed
Session detail |
Other Announcement |
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
08:00 ET premarket |
It gave back the whole move and closed 42.10% below the pre-news price. Month end -57.37% on 2024-03-28 |
| 34 | PACK | +51.72% |
against the close of 2024-03-11
session reconstructed
Session detail |
Earnings |
Ranpak Holdings Corp. Reports Fourth Quarter 2023 Financial Results
16:05 ET after hours |
Five sessions later the move was 36.7% bigger, at +70.71%. Month end +80.09% on 2024-03-28 |
| 35 | MNMD | +51.52% |
against the close of 2024-03-06
session reconstructed
Session detail |
FDA & Regulatory |
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
06:00 ET premarket |
28.1% of the move was gone five sessions later. Month end +58.25% on 2024-03-28 |
| 36 | GXAI under $25M today | +51.13% |
against the close of 2024-03-12
session reconstructed
Session detail |
M&A / Acquisition |
Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App
08:30 ET premarket |
11.0% of the move was gone five sessions later. Month end +15.41% on 2024-03-28 |
| 37 | NXL under $25M today More than one ranked move this month 2+ ranked moves | +49.55% |
against the close of 2024-03-05
session reconstructed
Session detail |
Clinical Trial Results |
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
08:30 ET premarket |
40.6% of the move was gone five sessions later. Month end +302.65% on 2024-03-28 |
| 38 | GOEV under $25M today Also on the opposite board this month on both boards | +49.48% |
against the close of 2024-03-15
session reconstructed
Session detail |
Other Announcement |
Canoo’s Oklahoma City Manufacturing Facility Approved as Foreign Trade Zone
06:00 ET premarket |
Five sessions later the move was 135.4% bigger, at +116.49%. Month end +84.02% on 2024-03-28 |
| 39 | ARQ | +46.69% |
against the close of 2024-03-12
session reconstructed
Session detail |
Earnings |
Arq Reports Fourth Quarter & Full Year 2023 Results
17:05 ET after hours |
Five sessions later the move was 87.0% bigger, at +87.32%. Month end +86.74% on 2024-03-28 |
| 40 | LICY More than one ranked move this month 2+ ranked moves | +46.32% |
against the close of 2024-03-11
session reconstructed
Session detail |
Contract / Partnership |
Li-Cycle Announces $75 Million Strategic Investment from Glencore
06:15 ET premarket |
Five sessions later the move was 410.7% bigger, at +236.57%. Month end +156.79% on 2024-03-28 |
| 41 | BGXX under $25M today | +45.72% |
against the close of 2024-03-11
session reconstructed
Session detail |
Other Announcement |
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
10:59 ET intraday |
22.4% of the move was gone five sessions later. Month end +16.50% on 2024-03-28 |
| 42 | LU | +45.70% |
against the close of 2024-03-20
session reconstructed
Session detail |
Earnings |
Lufax Reports Fourth Quarter and Full Year 2023 Financial Results
04:30 ET premarket |
44.8% of the move was gone five sessions later. Month end +25.22% on 2024-03-28 |
| 43 | PIII | +44.33% |
against the close of 2024-03-14
session reconstructed
Session detail |
Earnings |
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
08:00 ET premarket |
10.0% of the move was gone five sessions later. Month end +45.75% on 2024-03-28 |
| 44 | LICY More than one ranked move this month 2+ ranked moves | +44.09% |
against the close of 2024-03-15
session reconstructed
Session detail |
Earnings |
Li-Cycle Reports Full Year 2023 Results
17:30 ET after hours |
70.0% of the move was gone five sessions later. Month end +34.92% on 2024-03-28 |
| 45 | ENCP | +44.00% |
against the close of 2024-03-01
session reconstructed
Session detail |
Other Announcement |
Graphjet Technology Accelerates Production Timeline at State-of-the-Art Manufacturing Plant in Malaysia
11:11 ET intraday |
Five sessions later the move was 452.6% bigger, at +243.14%. Month-end is not shown: no closing price is available for 2024-03-28. |
| 46 | APGE | +42.07% |
against the close of 2024-03-04
session reconstructed
Session detail |
Clinical Trial Results |
Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule with Half-Life of Approximately 75 Days
06:00 ET premarket
|
Five sessions later the move was 57.2% bigger, at +66.12%. Month end +59.20% on 2024-03-28 |
| 47 | IVVD | +41.10% |
against the close of 2024-03-21
session reconstructed
Session detail |
FDA & Regulatory |
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
15:04 ET intraday |
8.7% of the move was gone five sessions later. Month end +43.69% on 2024-03-28 This month ended before the fifth session after the move. |
| 48 | GNS More than one ranked move this month 2+ ranked moves | +40.01% |
against the close of 2024-03-15
session reconstructed
Session detail |
M&A / Acquisition catalyst from a later release the same session |
Genius Group Release Additional Details of FatBrain AI Transaction
07:00 ET premarket |
It gave back the whole move and closed 7.69% below the pre-news price. Month end +13.60% on 2024-03-28 |
| 49 | AMTX | +39.73% |
against the close of 2024-03-20
session reconstructed
Session detail |
Other Announcement |
Aemetis Approved by USCIS for $200 million of EB-5 Investment in Biogas, SAF and Carbon Sequestration Projects
08:00 ET premarket |
Five sessions later the move was 61.4% bigger, at +64.11%. Month end +64.11% on 2024-03-28 |
| 50 | XPOF release reads negative | +39.38% |
against the close of 2024-02-29
session reconstructed
Session detail |
Earnings Release reads negative, stock rose 39.38% |
Xponential Fitness, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
16:05 ET after hours |
7.0% of the move was gone five sessions later. Month end +64.09% on 2024-03-28 |
| 51 | DNUT | +39.36% |
against the close of 2024-03-25
session reconstructed
Session detail |
Contract / Partnership |
McDonald’s® USA and Krispy Kreme® Announce Expanded National Partnership
06:00 ET premarket |
55.5% of the move was gone five sessions later. Month end +22.37% on 2024-03-28 This month ended before the fifth session after the move. |
| 52 | COCH | +39.20% |
against the close of 2024-03-01
session reconstructed
Session detail |
Clinical Trial Results |
Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
09:20 ET premarket |
49.0% of the move was gone five sessions later. Month end -37.28% on 2024-03-28 |
| 53 | SMLP | +38.96% |
against the close of 2024-03-21
session reconstructed
Session detail |
M&A / Acquisition |
Summit Midstream Partners, LP Announces Sale of Utica Position for $625 Million
08:30 ET premarket |
Five sessions later the move was 19.8% bigger, at +46.68%. Month end +44.47% on 2024-03-28 This month ended before the fifth session after the move. |
| 54 | ELVN | +38.77% |
against the close of 2024-03-18
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
08:30 ET premarket |
Five sessions later the move was 1.4% bigger, at +39.32%. Month end +39.16% on 2024-03-28 |
| 55 | STOK More than one ranked move this month 2+ ranked moves | +37.71% |
against the close of 2024-03-26
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Stoke Therapeutics Announces Proposed Public Offering
16:07 ET after hours |
51.6% of the move was gone five sessions later. Month end +31.20% on 2024-03-28 This month ended before the fifth session after the move. |
| 56 | APEI | +36.94% |
against the close of 2024-03-05
session reconstructed
Session detail |
Earnings |
American Public Education Reports Fourth Quarter and Full Year 2023 Results
16:01 ET after hours |
65.9% of the move was gone five sessions later. Month end +24.89% on 2024-03-28 |
| 57 | GNS More than one ranked move this month 2+ ranked moves | +36.90% |
against the close of 2024-03-13
session reconstructed
Session detail |
M&A / Acquisition |
Genius Group Completes FatBrain AI Merger, 150% Increase in 2023 Combined Proforma Revenue Guidance
14:10 ET intraday |
Five sessions later the move was 116.9% bigger, at +80.03%. Month end +64.48% on 2024-03-28 |
| 58 | SMXT under $25M today | +36.50% |
against the close of 2024-03-05
session reconstructed
Session detail |
Uplisting / Compliance |
SolarMax Technology, Inc. Announces Exercise of Overallotment Option From Initial Public Offering
16:01 ET after hours |
Five sessions later the move was 85.9% bigger, at +67.87%. Month end +73.95% on 2024-03-28 |
| 59 | ARBK | +35.63% |
against the close of 2024-03-27
session reconstructed
Session detail |
Crypto & Treasury |
Argo Blockchain PLC Announces Closing on Sale of Mirabel / TVR
03:00 ET premarket |
It gave back the whole move and closed 0.63% below the pre-news price. Month end +35.63% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 60 | RETO under $25M today | +35.51% |
against the close of 2024-03-20
session reconstructed
Session detail |
Uplisting / Compliance |
ReTo Regained Compliance with Nasdaq's Minimum Bid Price Requirement and Received Extension on Compliance with Nasdaq's Minimum Stockholders' Equity Rule
16:30 ET after hours |
It gave back the whole move and closed 20.29% below the pre-news price. Month end -20.29% on 2024-03-28 |
| 61 | WULF | +35.47% |
against the close of 2024-03-19
session reconstructed
Session detail |
Earnings |
TeraWulf Reports Fourth Quarter and Full Year 2023 Results
16:05 ET after hours |
Five sessions later the move was 60.6% bigger, at +56.98%. Month end +52.91% on 2024-03-28 |
| 62 | NN Also on the opposite board this month on both boards | +35.22% |
against the close of 2024-03-08
session reconstructed
Session detail |
M&A / Acquisition |
NextNav To Acquire Additional Lower 900 MHz Band Spectrum Licenses
08:30 ET premarket |
38.7% of the move was gone five sessions later. Month end +69.15% on 2024-03-28 |
| 63 | DWAC Also on the opposite board this month on both boards | +35.22% |
against the close of 2024-03-22
session reconstructed
Session detail |
Reverse Merger / Shell |
Digital World Acquisition Corp. Stockholders Approve the Proposed Merger With Trump Media & Technology Group Corp.
17:50 ET after hours |
Month-end is not shown: no closing price is available for 2024-03-28. This month ended before the fifth session after the move. |
| 64 | OUST | +34.54% |
against the close of 2024-03-26
session reconstructed
Session detail |
Other Announcement |
Ouster Announces Record Revenue for Fourth Quarter and Full Year 2023
16:15 ET after hours |
Five sessions later the move was 191.3% bigger, at +100.60%. Month end +59.44% on 2024-03-28 This month ended before the fifth session after the move. |
| 65 | HIPO | +34.09% |
against the close of 2024-03-05
session reconstructed
Session detail |
Earnings |
Hippo Reports Fourth Quarter 2023 Financial Results
07:00 ET premarket |
10.9% of the move was gone five sessions later. Month end +26.35% on 2024-03-28 |
| 66 | FLGC under $25M today | +33.90% |
against the close of 2024-03-21
session reconstructed
Session detail |
Other Announcement |
Flora Growth Corp. Provides Update on Germany's Cannabis Legalization
10:33 ET intraday |
Five sessions later the move was 175.0% bigger, at +93.22%. Month end +95.76% on 2024-03-28 This month ended before the fifth session after the move. |
| 67 | VSTE under $25M today | +33.77% |
against the close of 2024-03-27
session reconstructed
Session detail |
Earnings |
Vast Renewables Limited Announces Operational and Financial Results for First Half of Fiscal 2024
01:15 ET premarket |
Five sessions later the move was 534.6% bigger, at +214.29%. Month end +33.77% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 68 | REX | +33.67% |
against the close of 2024-03-27
session reconstructed
Session detail |
Earnings |
REX American Resources Reports Full Fiscal Year 2023 Net Income Per Share Attributable to REX Common Shareholders of $3.47, the Second Highest in Company History
06:00 ET premarket |
Five sessions later the move was 0.6% bigger, at +33.88%. Month end +33.67% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 69 | NTRB | +33.22% |
against the close of 2024-03-26
session reconstructed
Session detail |
Other Announcement |
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
05:50 ET premarket |
Five sessions later the move was 23.3% bigger, at +40.95%. Month end +48.68% on 2024-03-28 This month ended before the fifth session after the move. |
| 70 | HTOO under $25M today | +32.56% |
against the close of 2024-03-01
session reconstructed
Session detail |
Other Announcement |
Fusion Fuel Receives €1 Million Grant from European Innovation Fund for Alentejo Green Hydrogen Valley through H2tALENT Consortium
04:00 ET premarket |
19.0% of the move was gone five sessions later. Month end +31.01% on 2024-03-28 |
| 71 | PAVM | +32.52% |
against the close of 2024-03-26
session reconstructed
Session detail |
Earnings |
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
19:32 ET after hours |
73.1% of the move was gone five sessions later. Month end +3.88% on 2024-03-28 This month ended before the fifth session after the move. |
| 72 | CELZ under $25M today | +32.35% |
against the close of 2024-03-06
session reconstructed
Session detail |
FDA & Regulatory |
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
09:15 ET premarket |
72.4% of the move was gone five sessions later. Month end +9.45% on 2024-03-28 |
| 73 | WNNR | +32.04% |
against the close of 2024-03-27
session reconstructed
Session detail |
Reverse Merger / Shell |
Zapata AI and Andretti Acquisition Corp. Announce Closing of Business Combination
10:30 ET intraday |
Month end +32.04% on 2024-03-28 same session This month ended before the fifth session after the move. |
| 74 | YS | +32.03% |
against the close of 2024-03-04
session reconstructed
Session detail |
Other Announcement |
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
08:00 ET premarket |
Five sessions later the move was 46.2% bigger, at +46.82%. Month end +56.33% on 2024-03-28 |
| 75 | JEWL under $25M today | +31.90% |
against the close of 2024-03-25
session reconstructed
Session detail |
Other Announcement |
Adamas One Corp. Announces Establishment of Board of Advisors for Adamas One Technologies
08:45 ET premarket |
52.9% of the move was gone five sessions later. Month end +33.90% on 2024-03-28 This month ended before the fifth session after the move. |
| 76 | LASE | +31.82% |
against the close of 2024-03-20
session reconstructed
Session detail |
Contract / Partnership |
Laser Photonics Corporation Enters Distribution Agreement With Incredible Supply & Logistics for Its Military & Industrial Laser Solutions
07:00 ET premarket |
71.4% of the move was gone five sessions later. Month end +9.09% on 2024-03-28 |
| 77 | NVEI | +31.80% |
against the close of 2024-03-15
session reconstructed
Session detail |
No Stated Cause |
Nuvei responds to recent press reports
23:01 ET after hours |
Five sessions later the move was 1.6% bigger, at +32.31%. Month end +45.31% on 2024-03-28 |
| 78 | DELL | +31.62% |
against the close of 2024-02-29
session reconstructed
Session detail |
Earnings |
Dell Technologies Delivers Fourth Quarter and Full Year Fiscal 2024 Financial Results
16:05 ET after hours |
27.9% of the move was gone five sessions later. Month end +20.55% on 2024-03-28 |
| 79 | TSHA | +31.56% |
against the close of 2024-03-19
session reconstructed
Session detail |
Earnings |
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
16:01 ET after hours |
Five sessions later the move was 29.6% bigger, at +40.89%. Month end +27.56% on 2024-03-28 |
| 80 | WVE | +31.32% |
against the close of 2024-03-05
session reconstructed
Session detail |
Earnings |
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
07:30 ET premarket |
Five sessions later the move was 36.3% bigger, at +42.69%. Month end +28.81% on 2024-03-28 |
| 81 | MYO | +31.05% |
against the close of 2024-02-29
session reconstructed
Session detail |
Earnings |
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
16:05 ET after hours |
86.3% of the move was gone five sessions later. Month end +6.86% on 2024-03-28 |
| 82 | GMM under $25M today | +30.69% |
against the close of 2024-03-08
session reconstructed
Session detail |
Other Announcement |
Global Mofy Metaverse Announces New Subsidiary for AI Technology Monetization and Synthetic Video Content Creation
08:30 ET premarket |
It gave back the whole move and closed 48.66% below the pre-news price. Month end -56.46% on 2024-03-28 |
| 83 | SDPI | +30.53% |
against the close of 2024-03-06
session reconstructed
Session detail |
M&A / Acquisition |
Drilling Tools International Corp. to Acquire Superior Drilling Products, Inc.
06:00 ET premarket |
10.0% of the move was gone five sessions later. Month end +29.68% on 2024-03-28 |
| 84 | SPIR Also on the opposite board this month on both boards | +30.37% |
against the close of 2024-03-18
session reconstructed
Session detail |
Contract / Partnership |
Spire Global to Enhance AI-Driven Weather Prediction in Collaboration with NVIDIA
18:00 ET after hours |
It gave back the whole move and closed 5.21% below the pre-news price. Month end -2.28% on 2024-03-28 |
| 85 | KULR | +30.36% |
against the close of 2024-03-25
session reconstructed
Session detail |
Contract / Partnership |
KULR Enters into an Agreement with Lockheed Martin for Heat Sink Advancements in Precision Missile Electronics
08:30 ET premarket |
Five sessions later the move was 287.0% bigger, at +117.50%. Month end +16.89% on 2024-03-28 This month ended before the fifth session after the move. |
| 86 | JYNT release reads negative | +29.98% |
against the close of 2024-03-07
session reconstructed
Session detail |
Earnings Release reads negative, stock rose 29.98% |
The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results
16:20 ET after hours |
Five sessions later the move was 31.8% bigger, at +39.50%. Month end +42.89% on 2024-03-28 |
| 87 | FTK | +29.89% |
against the close of 2024-03-12
session reconstructed
Session detail |
Earnings |
Flotek Reports Fourth Quarter and Full-Year 2023 Results Highlighted by Growth in All Profitability Metrics Including a $31 Million Improvement in Annual Gross Profit
16:02 ET after hours |
2.4% of the move was gone five sessions later. Month end +33.10% on 2024-03-28 |
| 88 | QSI | +29.81% |
against the close of 2024-03-06
session reconstructed
Session detail |
Other Announcement |
Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference
12:01 ET intraday |
66.7% of the move was gone five sessions later. Month end +22.36% on 2024-03-28 |
| 89 | ARBE | +29.53% |
against the close of 2024-03-20
session reconstructed
Session detail |
Other Announcement |
Arbe Opens an Office in Shanghai, China, Solidifying the Company’s Presence in the Region
16:01 ET after hours |
71.9% of the move was gone five sessions later. Month end +8.29% on 2024-03-28 |
| 90 | LXRX | +29.49% |
against the close of 2024-03-08
session reconstructed
Session detail |
FDA & Regulatory |
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
07:00 ET premarket |
45.3% of the move was gone five sessions later. Month end +10.60% on 2024-03-28 |
| 91 | SWBI | +29.39% |
against the close of 2024-03-07
session reconstructed
Session detail |
Earnings |
Smith & Wesson Brands, Inc. Reports Third Quarter Fiscal 2024 Financial Results
16:15 ET after hours |
Five sessions later the move was 3.8% bigger, at +30.51%. Month end +29.17% on 2024-03-28 |
| 92 | MRAI under $25M today | +28.76% |
against the close of 2024-03-05
session reconstructed
Session detail |
Contract / Partnership |
MARPAI ANNOUNCES "OFF-CYCLE" NEW CLIENT AGREEMENT
16:00 ET after hours |
Five sessions later the move was 154.5% bigger, at +73.20%. Month end +59.48% on 2024-03-28 |
| 93 | XFOR | +28.43% |
against the close of 2024-03-20
session reconstructed
Session detail |
Earnings |
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
06:01 ET premarket |
Five sessions later the move was 27.6% bigger, at +36.27%. Month end +36.27% on 2024-03-28 |
| 94 | SG | +28.41% |
against the close of 2024-02-29
session reconstructed
Session detail |
Earnings |
Sweetgreen, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
16:05 ET after hours |
Five sessions later the move was 66.3% bigger, at +47.25%. Month end +98.27% on 2024-03-28 |
| 95 | ARRW | +28.25% |
against the close of 2024-03-26
session reconstructed
Session detail |
Reverse Merger / Shell |
Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders
21:18 ET after hours |
Five sessions later the move was 59.4% bigger, at +45.04%. Month end +28.25% on 2024-03-28 This month ended before the fifth session after the move. |
| 96 | ML | +28.18% |
against the close of 2024-03-06
session reconstructed
Session detail |
Earnings |
MoneyLion Announces Fourth Quarter and Full Year 2023 Results
07:30 ET premarket |
28.8% of the move was gone five sessions later. Month end +35.72% on 2024-03-28 |
| 97 | ELTX | +28.00% |
against the close of 2024-03-15
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
08:00 ET premarket |
Five sessions later the move was 35.7% bigger, at +38.00%. Month end +52.00% on 2024-03-28 |
| 98 | AVAV | +27.94% |
against the close of 2024-03-04
session reconstructed
Session detail |
Earnings |
AeroVironment Announces Fiscal 2024 Third Quarter Results
16:10 ET after hours |
14.1% of the move was gone five sessions later. Month end +17.32% on 2024-03-28 |
| 99 | STRO | +27.83% |
against the close of 2024-03-25
session reconstructed
Session detail |
Earnings |
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
16:30 ET after hours |
Five sessions later the move was 100.0% bigger, at +55.66%. Month end +72.78% on 2024-03-28 This month ended before the fifth session after the move. |
| 100 | ASST | +27.72% |
against the close of 2024-03-20
session reconstructed
Session detail |
Contract / Partnership |
Asset Entities Inc. Enters Into Agreement with Zendrop, the “#1 High Margin Dropshipping App”
08:00 ET premarket |
Five sessions later the move was 47.9% bigger, at +40.99%. Month end +40.99% on 2024-03-28 |
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 295 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band
4 candidate events for this board could not be anchored to a trading session and are not listed.
1 event was left out of this board because the stored move and the session's own closing prices disagree by far more than a measurement difference, so neither figure could be published.
1 event was left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.
2 events were left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.
1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.
1 row prints a move recomputed from the session's own closing prices, because the stored figure disagreed with them; each says so on the row, and each keeps the rank the stored figure gave it.
Company names are not shown on months older than a year, because only the current holder of each ticker is known.
Whole board, unfiltered
In March 2024, the median gainer had given back 6.1% of its move five sessions later; the largest catalyst group was Earnings, 31 of the 100 events, at a median of +34.1%.
Close-to-close change on the measured trading session, against the previous close.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
Which catalysts drove the board
Swipe the table sideways for the day +5 columns.
| Catalyst | Events | Share of board | Median move close to close | Median at day +5 | Still above the pre-news close at day +5 |
|---|---|---|---|---|---|
| Earnings | 31 | 31.0% | +34.1% | +39.9% | 100.0% of 31 |
| Other Announcement | 20 | 20.0% | +41.9% | +49.3% | 90.0% of 20 |
| M&A / Acquisition | 11 | 11.0% | +51.1% | +46.7% | 90.9% of 11 |
| Contract / Partnership | 11 | 11.0% | +39.4% | +80.5% of 10 | 90.0% of 10 |
| Clinical Trial Results | 7 | 7.0% | Fewer than 10 events in this group, so no figures are shown. | ||
The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.
8 other catalyst types, 20 events: Reverse Merger / Shell, FDA & Regulatory, Offering / Dilution, Uplisting / Compliance, Buyback / Dividend, Crypto & Treasury, Leadership Change, No Stated Cause.
How much of the move survived
| Horizon | Still above the pre-news close close to close | Median change since the measured close as a share of the move |
|---|---|---|
| Day +1 | 99.0% of 98 | 0.6% further above baseline, of 98 |
| Day +5 | 92.8% of 97 | 6.1% given back, of 97 |
| Month end | 94.4% of 90 | 1.7% further above baseline, of 90 |
| Month end falls before day +5 for 20 of these 90 events, so this row is not a later horizon than the one above it. 90 of the 100 events have a month-end close later than the measured session; 7 have it on the measured session itself, and 3 have no month-end close. | ||
Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.
Repeat runners
Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.
Moved twice or more inside March 2024
Two or more ranked moves this month, each on a different trading day.
| Symbol | Measured sessions | Best move |
|---|---|---|
| NXL | 2Clinical Trial Results | +79.49% |
| STOK | 2Earnings, Offering / Dilution | +58.31% |
| LICY | 2Contract / Partnership, Earnings | +46.32% |
| GNS | 2M&A / Acquisition | +40.01% |
Also risen on news in earlier months
Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.
| Symbol | Months | Best move |
|---|---|---|
| INBS | 2024-02, 2023-12 | +146.89% |
| ONMD | 2024-02, 2024-01 | +168.21% |
| ATRA | 2024-02, 2024-01 | +33.10% |
| SMCI | 2024-02, 2024-01 | +35.94% |
| WGS | 2024-02, 2024-01 | +40.36% |
| GETR | 2024-01, 2023-12 | +84.85% |
| SIDU | 2024-01, 2023-12 | +163.16% |
| DATS | 2024-01, 2023-12 | +58.25% |
| CYN | 2024-01, 2023-12 | +64.00% |
| GNSthis month too | 2024-01, 2023-12 | +28.77% |
| SNES | 2024-01, 2023-12 | +34.38% |
What the board was made of
Price before the move
Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.
When the announcement landed
Volume against normal
1 event has too little trading history for a relative volume, and is not in the tiers above.
Industry
39 other industries, 43 events
Industry not known: 22.0%
6 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.
Against February 2024
100 events in the comparable window.
February 2024 median +42.1%, selected from the 10,433 events in that month's eligible pool
March 2024 median +39.4%, 2.7 points below February 2024. March 2024's median is taken over the 100 ranked rows, selected from the 8,829 events in that month's eligible pool.
How this ranking is measured
Close-to-close change on the measured trading session, against the previous close.
- An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
- One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
- A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
- No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.
Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.
Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.
Market cap is not shown on months older than a year, because only today's figure exists.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
This archive starts at 2020-04, the first month with ranked moves.